HHLR Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,400
Closed -$10.2M 81
2024
Q2
$10.2M Buy
+18,400
New +$10.5M 0.25% 30
2023
Q4
Sell
-31,952
Closed -$16.2M 59
2023
Q3
$16.2M Sell
31,952
-9,500
-23% -$5.06M 0.36% 27
2023
Q2
$21.6M Buy
41,452
+15,652
+61% +$8.45M 0.46% 23
2023
Q1
$14.9M Buy
+25,800
New +$14.5M 0.26% 33

Other funds holding TMO

HHLR Advisors's TMO Position: Q3 2024 in Review

HHLR Advisors sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 18,400 shares — an estimated $10.2M sold.

HHLR Advisors first reported a position in TMO in Q1 2023 and held it in 4 quarters. The position peaked at $21.6M in Q2 2023. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

  • HHLR Advisors reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
  • HHLR Advisors sold 18,400 Thermo Fisher Scientific shares in Q3 2024, an estimated $10.2M.
  • HHLR Advisors first reported a position in Thermo Fisher Scientific in Q1 2023 and held it in 4 quarters.
  • HHLR Advisors's Thermo Fisher Scientific position peaked at $21.6M in Q2 2023.
  • 2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on HHLR Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.